Clinical Trial Update: MPP Programming Study [NA]

View source ↗

Summary

A status update indicates Abbott Medical Devices' MPP Programming Study (NCT01856725) in heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | NA | Status: COMPLETED